PT Millennium Pharmacon International Tbk (ISX:SDPC) Days Sales Outstanding : 77.37 (As of Sep. 2024)

View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk Days Sales Outstanding?

PT Millennium Pharmacon International Tbk's average Accounts Receivable for the three months ended in Sep. 2024 was Rp834,207 Mil. PT Millennium Pharmacon International Tbk's Revenue for the three months ended in Sep. 2024 was Rp983,826 Mil. Hence, PT Millennium Pharmacon International Tbk's Days Sales Outstanding for the three months ended in Sep. 2024 was 77.37.

The historical rank and industry rank for PT Millennium Pharmacon International Tbk's Days Sales Outstanding or its related term are showing as below:

ISX:SDPC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.09 Med: 56.3 Max: 73.49
Current: 73.49

During the past 13 years, PT Millennium Pharmacon International Tbk's highest Days Sales Outstanding was 73.49. The lowest was 52.09. And the median was 56.30.

ISX:SDPC's Days Sales Outstanding is ranked better than
50.93% of 108 companies
in the Medical Distribution industry
Industry Median: 73.8 vs ISX:SDPC: 73.49

PT Millennium Pharmacon International Tbk's Days Sales Outstanding increased from Sep. 2023 (74.08) to Sep. 2024 (77.37).

PT Millennium Pharmacon International Tbk Days Sales Outstanding Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk Days Sales Outstanding Chart

PT Millennium Pharmacon International Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

66.00

67.37

55.98

56.23

65.40

PT Millennium Pharmacon International Tbk Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															74.08	68.37	69.39	78.52	77.37

Competitive Comparison of PT Millennium Pharmacon International Tbk's Days Sales Outstanding

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Millennium Pharmacon International Tbk's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Days Sales Outstanding falls into.

PT Millennium Pharmacon International Tbk Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PT Millennium Pharmacon International Tbk's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (545672.462	+	659683.803)	/	2 )	/	3363517.808	*	365
=	602678.1325					/	3363517.808	*	365
=	65.40

PT Millennium Pharmacon International Tbk's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (842177.88	+	826236.145)	/	2 )	/	983825.881	*	365 / 4
=	834207.0125					/	983825.881	*	365 / 4
=	77.37

PT Millennium Pharmacon International Tbk (ISX:SDPC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PT Millennium Pharmacon International Tbk Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Millennium Pharmacon International Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan.Sultan Iskandar Muda No 18, Crown Bungur Arteri Lantai 2-4th Floors, Jakarta, IDN, 12240

Website

http://www.mpi-indonesia.co.id

PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines